text:
Patent US20070106135 - Method and system for providing basal profile modification in analyte ... - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsMethod and system for providing basal profile modification in insulin therapy for use with infusion devices includes periodically monitoring the analyte levels of a patient for a predetermined period of time in order to determine, based on the monitored analyte levels, an appropriate modification factor...http://www.google.com/patents/US20070106135?utm_source=gb-gplus-sharePatent US20070106135 - Method and system for providing basal profile modification in analyte monitoring and management systemsAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS20070106135 A1Publication typeApplicationApplication numberUS 11/267,724Publication dateMay 10, 2007Filing dateNov 4, 2005Priority dateNov 4, 2005Also published asCA2628563A1, EP1945095A2, EP1945095A4, US7766829, US8585591, US9323898, US20100274220, US20110071372, US20110077479, US20140074061, US20160193410, WO2007056638A2, WO2007056638A3Publication number11267724, 267724, US 2007/0106135 A1, US 2007/106135 A1, US 20070106135 A1, US 20070106135A1, US 2007106135 A1, US 2007106135A1, US-A1-20070106135, US-A1-2007106135, US2007/0106135A1, US2007/106135A1, US20070106135 A1, US20070106135A1, US2007106135 A1, US2007106135A1InventorsMark Sloan, Gary HayterOriginal AssigneeAbbott Diabetes Care, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (99), Referenced by (337), Classifications (16), Legal Events (2) External Links: USPTO, USPTO Assignment, EspacenetMethod and system for providing basal profile modification in analyte monitoring and management systems
DETAILED DESCRIPTION [0014] FIG. 1 illustrates a data monitoring and management system such as, for example, an analyte (e.g., glucose) monitoring and management system 100 in accordance with one embodiment of the present invention. The subject invention is further described primarily with respect to an analyte monitoring and management system for convenience and such description is in no way intended to limit the scope of the invention. It is to be understood that the analyte monitoring system may be configured to monitor a variety of analytes, e.g., lactate, and the like. [0015] Indeed, analytes that may be monitored include, for example, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. [0016] The analyte monitoring and management system 100 includes a sensor 101, a transmitter unit 102 coupled to the sensor 101, and a receiver unit 104 which is configured to communicate with the transmitter unit 102 via a communication link 103. The receiver unit 104 may be further configured to transmit data to a data processing terminal 105 for evaluating the data received by the receiver unit 104. Moreover, the data processing terminal in one embodiment may be configured to receive data directly from the transmitter unit 102 via a communication link 106 which may optionally be configured for bi-directional communication. [0017] Only one sensor 101, transmitter unit 102, communication link 103, receiver unit 104, and data processing terminal 105 are shown in the embodiment of the analyte monitoring and management system 100 illustrated in FIG. 1. However, it will be appreciated by one of ordinary skill in the art that the analyte monitoring and management system 100 may include one or more sensor 101, transmitter unit 102, communication link 103, receiver unit 104, and data processing terminal 105, where each receiver unit 104 is uniquely synchronized with a respective transmitter unit 102. Moreover, within the scope of the present invention, the sensor 101 may include a subcutaneous analyte sensor, a transcutaneous analyte sensor, an implantable analyte sensor, or a noninvasive analyte sensor such as a transdermal patch or an optical sensor (for example, infrared sensor). [0018] Moreover, within the scope of the present invention, the analyte monitoring system 100 may be a continuous monitoring system, or semi-continuous, or a discrete monitoring system. Additionally, within the scope of the present invention, the sensor 101 may include a subcutaneous analyte sensor or an implantable analyte sensor which is configured to be substantially wholly implanted in a patient. [0019] In one embodiment of the present invention, the sensor 101 is physically positioned in or on the body of a user whose analyte level is being monitored. The sensor 101 may be configured to continuously sample the analyte level of the user and convert the sampled analyte level into a corresponding data signal for transmission by the transmitter unit 102. In one embodiment, the transmitter unit 102 is mounted on the sensor 101 so that both devices are positioned on the user's body. The transmitter unit 102 performs data processing such as filtering and encoding on data signals, each of which corresponds to a monitored analyte level of the user, for transmission to the receiver unit 104 via the communication link 103. [0020] In one embodiment, the analyte monitoring system 100 is configured as a one-way RF communication path from the transmitter unit 102 to the receiver unit 104. In such embodiment, the transmitter unit 102 transmits the sampled data signals received from the sensor 101 without acknowledgement from the receiver unit 104 that the transmitted sampled data signals have been received. For example, the transmitter unit 102 may be configured to transmit the encoded sampled data signals at a fixed rate (e.g., at one minute intervals) after the completion of the initial power on procedure. Likewise, the receiver unit 104 may be configured to detect such transmitted encoded sampled data signals at predetermined time intervals. Alternatively, the analyte monitoring system 100 may be configured with a bi-directional RF (or otherwise) communication between the transmitter unit 102 and the receiver unit 104. [0021] Additionally, in one aspect, the receiver unit 104 may include two sections. The first section is an analog interface section that is configured to communicate with the transmitter unit 102 via the communication link 103. In one embodiment, the analog interface section may include an RF receiver and an antenna for receiving and amplifying the data signals from the transmitter unit 102, which are thereafter, demodulated with a local oscillator and filtered through a band-pass filter. The second section of the receiver unit 104 is a data processing section which is configured to process the data signals received from the transmitter unit 102 such as by performing data decoding, error detection and correction, data clock generation, and data bit recovery. [0022] In operation, upon completing the power-on procedure, the receiver unit 104 is configured to detect the presence of the transmitter unit 102 within its range based on, for example, the strength of the detected data signals received from the transmitter unit 102 or a predetermined transmitter identification information. Upon successful synchronization with the corresponding transmitter unit 102, the receiver unit 104 is configured to begin receiving from the transmitter unit 102 data signals corresponding to the user's detected analyte level. More specifically, the receiver unit 104 in one embodiment is configured to perform synchronized time hopping with the corresponding synchronized transmitter unit 102 via the communication link 103 to obtain the user's detected analyte level. [0023] Referring again to FIG. 1, the data processing terminal 105 in one embodiment may be configured to include a medication delivery unit such as an infusion device including, for example, an insulin pump, and which may be operatively coupled to the receiver unit 104. In such an embodiment, the medication delivery unit 105 may be configured to administer a predetermined or calculated insulin dosage based on the information received from the receiver unit 104. For example, as discussed in further detail below, the medication delivery unit 105 in one embodiment may be configured to deliver insulin based on pre-programmed basal profiles to diabetic patients, as well as to determine and/or administer one or more suitable bolus levels (e.g., carbohydrate bolus, and correction bolus). [0024] Referring again to FIG. 1, the receiver unit 104 may include a personal computer, a portable computer such as a laptop or a handheld device (e.g., personal digital assistants (PDAs)), and the like, each of which may be configured for data communication with the receiver via a wired or a wireless connection. Additionally, the receiver unit 104 may further be connected to a data network (not shown) for storing, retrieving and updating data corresponding to the monitored analyte levels of the patient. [0025] Furthermore, in one embodiment of the present invention, the receiver unit 104 or the data processing terminal 105, or both the receiver unit 104 and the data processing terminal 105 may be configured to incorporate a glucose, strip meter so as to be configured to include, for example, a test strip port for receiving a glucose test strip. In this embodiment of the present invention, the receiver unit 104 and the data processing terminal 105 may be configured to perform analysis upon the sample from the glucose test strip so as to determine the glucose level from the test strip. One example of such strip meter is Freestyles glucose meter commercially available from the assignee of the present invention, Abbott Diabetes Car, Inc. of Alameda Calif. [0026] Furthermore, within the scope of the present invention, the data processing terminal 105 may include an infusion device such as an insulin infusion pump or the like, which may be configured to administer insulin to patients, and which may be configured to communicate with the receiver unit 104 for receiving, among others, the measured glucose level. Alternatively, the receiver unit 104 may be configured to integrate an infusion device therein so that the receiver unit 104 is configured to administer insulin therapy to patients, for example, for administering and modifying basal profiles, as well as for determining appropriate boluses for administration based on, among others, the detected analyte levels received from the transmitter unit 102. [0027] Additionally, the transmitter unit 102, the receiver unit 104 and the data processing terminal 105 may each be configured for bi-directional wireless communication such that each of the transmitter unit 102, the receiver unit 104 and the data processing terminal 105 may be configured to communicate (that is, transmit data to and receive data from) with each other via the wireless communication link 103. More specifically, the data processing terminal 105 may in one embodiment be configured to receive data directly from the transmitter unit 102 via the communication link 106, where the communication link 106, as described above, may be configured for bi-directional communication. In this embodiment, the data processing terminal 105 which may include an insulin pump, may be configured to receive the analyte signals from the transmitter unit 102, and thus, incorporate the functions of the receiver 103 including data processing for managing the patient's insulin therapy and analyte monitoring. [0028] In one embodiment, the communication link 103 may include one or more of an RF communication protocol, an infrared communication protocol, a Bluetooth enabled communication protocol, an 802.11x wireless communication protocol, or an equivalent wireless communication protocol which would allow secure, wireless communication of several units (for example, per HIPPA requirements) while avoiding potential data collision and interference. [0029] FIG. 2 is a block diagram of the transmitter of the data monitoring and detection system shown in FIG. 1 in accordance with one embodiment of the present invention. Referring to the Figure, the transmitter 102 in one embodiment includes an analog interface 201 configured to communicate with the sensor 101 (FIG. 1), a user input 202, and a temperature detection section 203, each of which is operatively coupled to a transmitter processor 204 such as a central processing unit (CPU). As can be seen from FIG. 2, there are provided four contacts, three of which are electrodes—work electrode (W) 210, guard contact (G) 211, reference electrode (R) 212, and counter electrode (C) 213, each operatively coupled to the analog interface 201 of the transmitter 102 for connection to the sensor unit 201 (FIG. 1). In one embodiment, each of the work electrode (W) 210, guard contact (G) 211, reference electrode (R) 212, and counter electrode (C) 213 may be made using a conductive material that is either printed or etched, for example, such as carbon which may be printed, or metal foil (e.g., gold) which may be etched. [0030] Further shown in FIG. 2 are a transmitter serial communication section 205 and an RF transmitter 206, each of which is also operatively coupled to the transmitter processor 204. Moreover, a power supply 207 such as a battery is also provided in the transmitter 102 to provide the necessary power for the transmitter 102. Additionally, as can be seen from the Figure, clock 208 is provided to, among others, supply real time information to the transmitter processor 204. [0031] In one embodiment, a unidirectional input path is established from the sensor 101 (FIG. 1) and/or manufacturing and testing equipment to the analog interface 201 of the transmitter 102, while a unidirectional output is established from the output of the RF transmitter 206 of the transmitter 102 for transmission to the receiver 104. In this manner, a data path is shown in FIG. 2 between the aforementioned unidirectional input and output via a dedicated link 209 from the analog interface 201 to serial communication section 205, thereafter to the processor 204, and then to the RF transmitter 206. As such, in one embodiment, via the data path described above, the transmitter 102 is configured to transmit to the receiver 104 (FIG. 1), via the communication link 103 (FIG. 1), processed and encoded data signals received from the sensor 101 (FIG. 1). Additionally, the unidirectional communication data path between the analog interface 201 and the RF transmitter 206 discussed above allows for the configuration of the transmitter 102 for operation upon completion of the manufacturing process as well as for direct communication for diagnostic and testing purposes. [0032] As discussed above, the transmitter processor 204 is configured to transmit control signals to the various sections of the transmitter 102 during the operation of the transmitter 102. In one embodiment, the transmitter processor 204 also includes a memory (not shown) for storing data such as the identification information for the transmitter 102, as well as the data signals received from the sensor 101. The stored information may be retrieved and processed for transmission to the receiver 104 under the control of the transmitter processor 204. Furthermore, the power supply 207 may include a commercially available battery. [0033] The transmitter 102 is also configured such that the power supply section 207 is capable of providing power to the transmitter for a minimum of about three months of continuous operation after having been stored for about eighteen months in a low-power (non-operating) mode. In one embodiment, this may be achieved by the transmitter processor 204 operating in low power modes in the non-operating state, for example, drawing no more than approximately 1 μA of current. Indeed, in one embodiment, the final step during the manufacturing process of the transmitter 102 may place the transmitter 102 in the lower power, non-operating state (i.e., post-manufacture sleep mode). In this manner, the shelf life of the transmitter 102 may be significantly improved. Moreover, as shown in FIG. 2, while the power supply unit 207 is shown as coupled to the processor 204, and as such, the processor 204 is configured to provide control of the power supply unit 207, it should be noted that within the scope of the present invention, the power supply unit 207 is configured to provide the necessary power to each of the components of the transmitter unit 102 shown in FIG. 2. [0034] Referring back to FIG. 2, the power supply section 207 of the transmitter 102 in one embodiment may include a rechargeable battery unit that may be recharged by a separate power supply recharging unit so that the transmitter 102 may be powered for a longer period of usage time. Moreover, in one embodiment, the transmitter 102 may be configured without a battery in the power supply section 207, in which case the transmitter 102 may be configured to receive power from an external power supply source (for example, a battery) as discussed in further detail below. [0035] Referring yet again to FIG. 2, the temperature detection section 203 of the transmitter 102 is configured to monitor the temperature of the skin near the sensor insertion site. The temperature reading is used to adjust the analyte readings obtained from the analog interface 201. The RF transmitter 206 of the transmitter 102 may be configured for operation in the frequency band of 315 MHz to 322 MHz, for example, in the United States. Further, in one embodiment, the RF transmitter 206 is configured to modulate the carrier frequency by performing Frequency Shift Keying and Manchester encoding. In one embodiment, the data transmission rate is 19,200 symbols per second, with a minimum transmission range for communication with the receiver 104. [0036] Referring yet again to FIG. 2, also shown is a leak detection circuit 214 coupled to the guard electrode (G) 211 and the processor 204 in the transmitter 102 of the data monitoring and management system 100. The leak detection circuit 214 in accordance with one embodiment of the present invention may be configured to detect leakage current in the sensor 101 to determine whether the measured sensor data are corrupt or whether the measured data from the sensor 101 is accurate. [0037] Additional detailed description of the continuous analyte monitoring system, its various components including the functional descriptions of the transmitter are provided in U.S. Pat. No. 6,175,752 issued Jan. 16, 2001 entitled “Analyte Monitoring Device and Methods of Use”, and in application Ser. No. 10/745,878 filed Dec. 26, 2003 entitled “Continuous Glucose Monitoring System and Methods of Use”, each assigned to the Assignee of the present application, and the disclosures of each of which are incorporated herein by reference for all purposes. [0038] FIG. 3 is a flowchart illustrating the process for monitoring analyte levels and determining modification to a current basal profile in accordance with one embodiment of the present invention. Referring to FIG. 1, at step 301, the analyte levels such as the patient's analyte level is monitored for a predetermined period of time, and at step 302, the monitored analyte levels is stored in a data storage unit (for example, in one or more memory devices of the receiver unit 104 and/or the data processing terminal 105). Thereafter, at step 303, patient specific parameters are retrieved from the data processing terminal 105 and/or the receiver unit 104, as well as the current basal profile(s) which the patient is implementing to operate the infusion device for insulin delivery during the time period of the analyte monitoring discussed above. [0039] In one embodiment, patient specific parameters may include the type of insulin currently being infused into the patient, the patient's insulin sensitivity, insulin resistance level, level of insulin on board, the specific time period of the analyte monitoring, including the activities performed by the patient during that time period, or any other factors and variables that may have an impact upon the effectiveness of insulin therapy for the patient. [0040] Referring to FIG. 3, after retrieving the patient specific parameters and the current basal profile(s) that the patient is implementing in the infusion device at step 303, at step 304, the monitored analyte levels are retrieved and, based on one or more patterns from the analyte levels monitored and factoring in the current basal profile(s), a recommendation or modification to the current basal profile(s) is determined. Thereafter, the recommendation or modification to the current basal profiles(s) determined at step 304 is provided to the patient visually on a display or audibly, or a combination of visual and audio output, such that the patient may be able to decide whether the modification to the current basal profile(s) is appropriate or suitable to the patient. [0041] While the modification to the basal profile(s) is discussed above as output to the patient, within the scope of the present invention, the basal profile modification determined in accordance with one embodiment of the present invention may be provided to a health care provider so as to determine suitability of the modification to the current basal profile in view of the monitored analyte levels. Furthermore, in an alternate embodiment, the determined modification to the current basal profile may be provided to both the patient and the health care provider so that the patient is able to make an informed decision as to whether the recommended modification to the current basal profile is suitable for the patient in improving insulin therapy to better manage diabetes. [0042] Within the scope of the present invention, the modification to the current basal profile may include several factors that are considered including, for example, the current basal profile as a function of the time period during which insulin infusion takes place and analyte levels are monitored, the level of the analyte monitored as a function of time, patient specific parameters discussed above including, for example, patient's activities during the monitored time period, patient's diet, insulin sensitivity, level of insulin on board, and the insulin type, and the frequency of bolus dosing during the time period of the analyte level monitoring (for example, the number of correction bolus dosing, and/or carbohydrate dosing). [0043] In this manner, in one embodiment of the present invention, the modification to the current basal profile(s) may be achieved for one or more specific goals for the patient's diabetes management, including for example, elimination of extreme glucose excursions, automating or semi-automating routine or regular bolus dosing, and adjustment to the mean glucose value. [0044] For example, to effectively eliminate extreme glucose excursions, the modification to the current basal profiles may be configured to provide recommendation to modify to reduce extreme levels, so that unless the monitored glucose level exceeds a predetermined threshold level (e.g, 200 mg/dL), modification to the current basal profile is not recommended. In the case of automating regular bolus dosing, based on the monitored analyte levels, a regular correction bolus dosing during the current basal profile implantation may be converted into a modification to the current basal profile so that the patient may effectively rid of the need to implement routine correction type bolus dosing. Additionally, with the collected data from the continuously monitored analyte levels, the current basal profile may be modified to adjust the mean target glucose value even in the case where extreme excursions of glucose levels do not occur. [0045] Within the scope of the present invention, the current basal profile modification may be performed at different times during the time that the patient is using an infusion device. For example, the patient may perform the current basal profile modification procedure discussed above on a daily basis if, for example, glucose excursions are anticipated on a regular basis. Alternatively, the current basal profile modification procedure may be performed each time a bolus is administered. [0046] Moreover, within the scope of the present invention, when a pattern of glucose excursions is detected over several days (for example, 48 or 72 hours), the analyte monitoring and management system 100 (FIG. 1) may be configured to continue analyte level monitoring to determine whether a pattern exists in the frequency and/or level of the glucose excursions. In such a case, it is possible to modify the current basal profile modification procedure to correct for such patterns in the monitored analyte levels such that the modification to the current basal profile may address such excursions [0047] In a further embodiment, the loop gain setting may be configured to determine the appropriate level of modification to the current basal profiles for a given glucose excursion pattern detected based on the monitored analyte levels. While several iterations may be necessary for low loop gain to reach the optimal modification level of the current basal profile, a conservative and less aggressive modification may be recommended in such cases. For medium loop gain, when critically controlled, the determined recommendation for modification to the current basal profile may be reached based on one iteration, but with the potential for an increased risk for overshoot and thereby resulting in over-compensation. Notwithstanding, the loop gain setting may be trained into the analyte monitoring and management system 100 so that by starting with a low loop gain and then learning the loop responses to reach the optimal loop gain, the desired modification to the current basal profile may be determined and provided to the patient. [0048] FIGS. 4A-4C illustrate a current basal profile, a monitored analyte level profile, and a modified basal profile recommendation respectively, in accordance with one embodiment of the present invention. Referring to FIG. 4A, a profile of the glucose level as a function of time is shown for a current basal profile programmed into the infusion device of the patient. FIG. 4B illustrates a profile of the glucose levels as a function of time for the same time period during which the basal profile shown in FIG. 4A is administered to the patient. Finally, FIG. 4C illustrates a profile of glucose level as a function of time which factors in the patient parameters including the monitored glucose levels of the patient, to provide a modification to the current basal profile so as to improve the patient's insulin therapy. [0049] Indeed, in one embodiment of the present invention, it can be seen that the analyte level monitoring and detecting patterns in the monitored analyte levels during the time period that the patient is using an infusion device such as an insulin pump running a pro-programmed basal profile, provides contemporaneous patient response of the infused insulin based on the current basal profile, and thus, it is possible to improve the insulin therapy. [0050] By way of an example, in the case that the patient desired to eliminate or substantially reduce the occurrences of high glucose extremes or excursions, it is determined whether there is a consistent pattern of high glucose levels versus time of day of such occurrence based on the monitored glucose levels. An example of such monitored levels is shown in the Table 1 below: TABLE 1 High Glucose Excursions 00:00 00:30 01:00 01:30 23:30 Day 1 (0-24 hr) 1 1 Day 2 (24-48 hr) 1 1 1 Day 3 (48-72 hr) 1 1 1 Sum 2 1 3 2 0 where over a 72 hour period post calibration of the sensor 101 (FIG. 1), the monitored data is reviewed to determine if the monitored glucose level exceeds a predetermined threshold level. Each occurrence of when the glucose level exceeds a predetermined threshold level is shown with a “1” in Table 1 above. [0051] For each column shown in Table 1 where the sum of the data entry equals “3”, and the sum of the adjacent columns is equal to or greater than “1”, the analyte monitoring and management system 100 in one embodiment may be configured to recommend an increase to the current basal profile for that time slot or period during the 72 hour period. [0052] More specifically, using a conventional bolus calculation mechanism, a correction bolus may be determined based on the detection of the high glucose level. Thereafter, rather than implementing the calculated correction bolus, the modification to the current basal profile may be determined based on the following relationship: Modification=K*Calculated Correction Bolus/30 minutes (1) [0053] where K is a loop gain value determined by the patient's health care provider, and is typically less than 1 for over dampened control, and further, where the 30 minutes is a scaling factor for the Modification determination. [0054] After the calculation, the determined Modification from the equation (1) above is provided to the patient to either accept and implement, storage for further analysis or modification, or reject. [0055] In one embodiment, the Modification determination based on relationship described in the equation (1) above may include glucose rate or higher derivative information, or alternatively, may also include an integral factor. In a further embodiment, the determination may also factor in the glucose profile variation. Other potentially relevant factors also include the physiological dynamics and/or sensor/monitor dynamics, as well as the patient's insulin infusions, caloric intake, exercise, etc. [0056] As another example, in the case where correction bolus dosing may be replaced with modification to the current basal profiles based on the monitored analyte levels, a consistent pattern in the monitored analyte levels of bolus delivery versus time of day is determined. Table 2 below shows one example of such pattern: TABLE 2 Bolus Replacement 00:00 00:30 01:00 01:30 23:30 Day 1 (0-24 hr) 1 1 Day 2 (24-48 hr) 1 1 1 Day 3 (48-72 hr) 1 1 1 Sum 2 1 3 2 0 [0057] Referring to Table 2 and in conjunction with equation (1) discussed above, the administration of bolus doses is reviewed and if, for example, there were three bolus deliveries (each shown in Table 2 with a “1” entry) within 30 minutes of the same time of day period, then an increase in the insulin level for same time period may be proposed to the current basal profile using equation (1) to determine the level of modification to the current basal profile. [0058] In the case of addressing the occurrence of low extremes of glucose levels, similar determinations as above may be performed given the monitored analyte levels for the desired time period and data reviewed for detection of patterns in the monitored analyte levels associated with the occurrences of low extremes. For example, Table 3 below provides data for a three day period illustrating patterns associated with the occurrences of low extremes. TABLE 3 Low Extremes Pattern 00:00 00:30 01:00 01:30 23:30 Day 1 (0-24 hr) 1 1 Day 2 (24-48 hr) 1 1 1 Day 3 (48-72 hr) 1 1 1 Sum 2 1 3 2 0 [0059] where the “1” entry in a particular column illustrates the occurrence of the measured glucose level that is below a predetermined low threshold level. [0060] Again, in conjunction with equation (1) above, a modification to the current basal profile may be determined and provided to the patient. More specifically, where over a 72 hour period post calibration of the sensor 101 (FIG. 1), the monitored data is reviewed to determine if the monitored glucose level falls below the predetermined low threshold level, each such is shown with a “1” in Table 3 above. [0061] For each column shown in Table 3 where the sum of the data entry equals “3”, and the sum of the adjacent columns is equal to or greater than “1”, the analyte monitoring and management system 100 in one embodiment may be configured to recommend a modification to the current basal profile for that time slot or period during the 72 hour period based on the relationship set forth in equation (1). The user or patient may then be provided with the modification to the current basal profile which may be accepted for implementation, stored for further analysis or modification, or rejected by the patient. [0062] In the case of reducing the mean glucose level using the analyte monitoring and management system 100 in one embodiment of the present invention, again, consistent patterns in the monitored analyte levels over a predetermined time period is analyzed and detected as a function of time of day of the analyte level monitoring. Table 4 below shows an example of such pattern: TABLE 4 Mean Glucose Level 00:00 00:30 01:00 01:30 23:30 Day 1 (0-24 hr) 1 1 Day 2 (24-48 hr) 1 1 1 Day 3 (48-72 hr) 1 1 1 Sum 2 1 3 2 0 [0063] where, an entry of a “1” in Table 4 above illustrates a detected glucose level of greater than a predetermined level (e.g., 120) during the three day period based on the data from the sensor 101 (FIG. 1). [0064] Again, similar to the determinations above, if the sum of any column in Table 4 is equal to three, and the sum of the adjacent columns is greater than or equal to one, then a decrease in the current basal profile for that particular time slot is recommended based on the relationship set forth above in equation (1). [0065] In a further embodiment, a 24 hour profile may be determined based on time-of-day averages over a predetermined number of days. The correction factor may then be based on maintaining the time-of-day averages within a predetermined target range value. Within the scope of the present invention, the various approaches and implementations for correction calculation and/or basal profile modification recommendation may be combined or implemented individually, depending upon the patient's physiology and the criteria for drug therapy such as insulin therapy. [0066] In accordance with the various embodiments of the present invention, additional or alternative approaches to the determination of the modification to the basal profile may include, for example, (1) modifying the basal rate by a constant value, (2) changing the basal rate by a constant percentage of the current basal profile rate, (3) changing the basal rate in proportion to the magnitude of the error, or (4) changing the basal rate in proportion to the magnitude of the error, compensating for the loop gain factor based on the affects of the previous basal rate modifications/adjustments. Each of these approaches within the scope of the present invention is described in further detail below. [0067] In the first embodiment described above, the basal rate is configured for modification by a constant amount. For example, the modification is described by the following equation (2): Modification=sign(measured−target)*U (2) [0068] where U is a constant value in insulin units, and is applied to the difference between the target glucose and measured glucose levels. [0069] Moreover, the “sign(measured−target)” relationship holds the following: if(measured−target)=0, then 0 else if (measured−target)>0, then +1 else if (measured−target)<0, then −1 [0073] For example, in the equation (2) above, the constant value U may be 0.1 units of insulin/hour. This may be a configurable value. Indeed, for the case where U is 0.1 units, if the measured glucose level is 140, while the target glucose level is 100, then the Modification to the basal rate would result in +1*0.1 equaling 0.1 units/hour. [0074] In this manner, in one embodiment, a simple and effective basal rate modification approach is provided and which does not require knowledge of the patient's physiology, is simple to implement, and does not provide resolution issues. On the other hand, for safely values of the contact factor U, several iterations or corrections may be needed to reach the desired results. [0075] In another embodiment, the basal rate may be modified by a constant percentage of the current rate. In this case, the following equation (3) holds: Modification=sign(measured−target)*K*U (3) [0076] where K=constant percentage, 0<=K<=1, and U=current basal rate (in units of insulin). [0077] For example, where the constant percentage K is 0.1 and with the current basal rate U of 2.0 units/hour, and for example, the measured and target glucose levels at 140 and 100, respectively, the basal rate Modification in accordance with the equation (3) equals +1*0.1*2.0=0.2 units/hour. In this manner, in one embodiment, a simple and effective way to implement basal rate modification is provided, and which does not require the knowledge of the user's physiology. For safe values of the constant percentage K, several iterations may be needed to reach the desired level of basal rate modification, and resolution issues may potentially arise. [0078] In a further embodiment of the present invention, the modification to the basal rate may be determined by changing the basal rate proportional to the magnitude of the error. In this case, the following equation (4) holds: Modification=(measured−target)*K*P (4) [0079] where K is the loop gain factor, and for example, K<1 for dampened control, K=1 for critical control, K>1 for over control, and further, where P is the patient's physiological response to insulin (insulin sensitivity). [0080] For example, in the case where the loop gain factor K is 0.75, the patient's insulin sensitivity P is 0.02 units/mg/dL, and where the measured and target glucose levels are 140 and 100, respectively, the Modification to the basal rate in accordance to equation (4) is determined to be (140−100)*0.75*0.02=0.6 units/hour. This approach requires prior determination of the patient's insulin sensitivity, and may likely require less iterations or corrective routines to reach the desired level of basal rate modification for effective treatment. [0081] In still a further embodiment, the modification to the basal rate may be determined by the changing the basal rate proportional to the magnitude of error, and further making adjustment to the loop gain factor based on the results of the prior basal rate adjustments. For example, the following equation (5) holds: [0082] with K=f(affect of last adjustment) Modification=(measured−target)*K*P (5) [0083] where K is loop gain factor, and P is the patient's physiology response to insulin (insulin sensitivity). [0084] For example, if the loop gain factor is initially 0.75, then the determined basal rate modification is the same as in the embodiment described above in conjunction with equation (4). In the next iteration, with the measured glucose level still higher than the target level, the look gain factor is increased. In this case, for example, with measured glucose level of 110 where the target level is 100, the new loop gain factor K is determined to be ((first delta)/(first change))*old K=(40/30)*0.75=1.00. [0085] Having determined the new loop gain factor K, the basal rate modification is determined by equation (5) as (110-100)*1.00*0.02=0.2 units/hour. It is to be noted that if the loop gain factor K did not change between the two iterations described above, then the basal rate modification in the second iteration may be relatively smaller, and it can be seen that the adjustment to the loop gain factor allows faster settling to the final value. For example, using equation (5) above, the basal rate modification is determined as: Modification=(110−100)*0.75*0.02=0.15 units/hour [0086] In this manner, in one embodiment of the present invention, the basal rate modification may be configured to self adjust to the patient's physiology such that it may be more tolerant of inaccurate input values. [0087] In this manner, the various embodiments of the present invention provides a mechanism for diabetic patients to compare the actual glucose levels during a predetermined time period and to use that information in addition to the actual basal profile to recommend a new or modified basal profile to the patient. The patient will have the option to accept the recommendation, the accept the recommendation with the modification, or alternatively to decline the proposed modified basal profile so as to select the most appropriate basal profile for the patient. [0088] Moreover, contrasting with real time closed loop insulin therapy where the insulin infusion is modified at a rate (i.e., minutes) much faster than the physiological response times, one embodiment of the present invention is characterized by a) corrections to basal profiles that are made over periods (i.e., days) which are much longer than physiological response times, and b) corrections based on repeating diurnal glucose patterns. In this manner, in one embodiment, the present invention is configured to identify the patient's glucose levels retrospectively over a predetermined period of time (for example, over a 24 hour period) to determine any recommended modification to the existing basal profiles. In this manner, the recommended modification to the basal profiles will be a function of the actual measured glucose values of the patient under the existing basal profiles. [0089] In the manner described above, in accordance with the various embodiments of the present invention, the patient and the doctor or educator may work together to adjust the insulin profile to the patient's activities. This will require experience and some trial and error as well. An automated basal profile correction in accordance with the embodiments of the present invention may monitor and gather much more information and may incorporate the knowledge of the physician/educator within the modification algorithm. Indeed, different objectives can be identified and the modification algorithms developed to achieve the objectives. [0090] Accordingly, a method in one embodiment includes monitoring an analyte level of a patient, retrieving a predetermined parameter, and determining a modification to an drug therapy profile based on the monitored analyte level and the predetermined parameter. [0091] The analyte includes glucose, and the drug infusion rate may include a basal profile. [0092] Further, the predetermined parameter may include one or more of an insulin sensitivity, a drug infusion rate, and a drug infusion time period, a time period corresponding to the monitored analyte level, a time of day associated with the monitored analyte level, or a loop gain factor. [0093] Moreover, the monitoring step may include determining the analyte level of the patient at a predetermined time interval including one of 5 minutes, 30 minutes, 1 hour, or 2 hours. [0094] The method in one embodiment may further including the step of outputting the modification to the drug therapy profile to the patient. [0095] Also, the method may additionally include the step of implementing the modification to the drug therapy profile. [0096] In a further aspect, the drug therapy profile may include an insulin infusion profile. [0097] A system in yet another embodiment of the present invention includes an analyte monitoring unit, and a processing unit operatively coupled to the analyte monitoring unit, the processing unit configured to receive a plurality of monitored analyte levels of a patient, and to determine a modification to a drug therapy profile based on the received plurality of monitored analyte levels. [0098] The analyte monitoring unit in one embodiment may include a sensor unit provided in fluid contact with an analyte of a patient. [0099] Further, the sensor unit may include a subcutaneous analyte sensor, a transcutaneous analyte sensor, and a transdermal patch sensor. [0100] Moreover, the processing unit may be operatively coupled to an infusion device. [0101] In a further aspect, the processing unit may include an insulin pump. [0102] Moreover, in still another aspect, the processing unit may be is configured to determine the modification based on a pattern in the monitored analyte level, where the pattern may be determined based on the plurality of monitored analyte levels for a predetermined time period, and further, where the predetermined time period may include one of a 12 hour period, or 24 hour period. [0103] The system in yet another embodiment may include a display unit operatively coupled to the processing unit for displaying the determined modification. [0104] Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present invention and that structures and methods within the scope of these claims and their equivalents be covered thereby. Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3304413 *Mar 26, 1963Feb 14, 1967Hewlett Packard CoCardiac output computerUS3651318 *Jan 26, 1970Mar 21, 1972Jan A CzekajewskiCardiac output computerUS3653841 *Dec 19, 1969Apr 4, 1972Hoffmann La RocheMethods and compositions for determining glucose in bloodUS3719564 *May 10, 1971Mar 6, 1973Philip Morris IncMethod of determining a reducible gas concentration and sensor thereforUS3949388 *Mar 26, 1975Apr 6, 1976Monitron Industries, Inc.Physiological sensor and transmitterUS4008717 *Mar 5, 1976Feb 22, 1977The Johns Hopkins UniversitySystem for continuous withdrawal and analysis of bloodUS4016866 *Dec 18, 1975Apr 12, 1977General Electric CompanyImplantable electrochemical sensorUS4068536 *Dec 23, 1976Jan 17, 1978Cincinnati Milacron Inc.ManipulatorUS4076596 *Oct 7, 1976Feb 28, 1978Leeds & Northrup CompanyApparatus for electrolytically determining a species in a fluid and method of useUS4245634 *Feb 12, 1979Jan 20, 1981Hospital For Sick ChildrenArtificial beta cellUS4247297 *Feb 23, 1979Jan 27, 1981Miles Laboratories, Inc.Test means and method for interference resistant determination of oxidizing substancesUS4318784 *Apr 15, 1980Mar 9, 1982National Research Development CorporationEnzymatic processesUS4375399 *Dec 19, 1980Mar 1, 1983Radelkis Elektrokemiai Miszergyarto SzovetkezetMolecule selective sensor for industrial use and procedure for its preparationUS4425920 *Oct 24, 1980Jan 17, 1984Purdue Research FoundationApparatus and method for measurement and control of blood pressureUS4427004 *Mar 16, 1981Jan 24, 1984Viridan Inc.Annular flow entrainment nebulizerUS4427770 *Jun 14, 1982Jan 24, 1984Miles Laboratories, Inc.High glucose-determining analytical elementUS4431004 *Oct 27, 1981Feb 14, 1984Bessman Samuel PImplantable glucose sensorUS4436094 *Jan 27, 1982Mar 13, 1984Evreka, Inc.Monitor for continuous in vivo measurement of glucose concentrationUS4440175 *Aug 10, 1981Apr 3, 1984University Patents, Inc.Membrane electrode for non-ionic speciesUS4444892 *May 17, 1982Apr 24, 1984Malmros Mark KAnalytical device having semiconductive organic polymeric element associated with analyte-binding substanceUS4494950 *Jan 19, 1982Jan 22, 1985The Johns Hopkins UniversityPlural module medication delivery systemUS4509531 *Jul 28, 1982Apr 9, 1985Teledyne Industries, Inc.Personal physiological monitorUS4512348 *Apr 23, 1982Apr 23, 1985Kabushiki Kaisha Kyoto Daiichi KagakuDevice for automatically and continuously measuring the constituent parts of bloodUS4569589 *May 25, 1983Feb 11, 1986University Of PennsylvaniaLung water computer systemUS4571292 *Aug 12, 1982Feb 18, 1986Case Western Reserve UniversityApparatus for electrochemical measurementsUS4573994 *Dec 7, 1981Mar 4, 1986The Johns Hopkins UniversityRefillable medication infusion apparatusUS4581336 *Oct 5, 1983Apr 8, 1986Uop Inc.Surface-modified electrodesUS4633878 *Apr 10, 1984Jan 6, 1987Guiseppe BombardieriDevice for the automatic insulin or glucose infusion in diabetic subjects, based on the continuous monitoring of the patient's glucose, obtained without blood withdrawalUS4633881 *Jul 1, 1982Jan 6, 1987The General Hospital CorporationAmbulatory ventricular function monitorUS4637403 *Jun 14, 1985Jan 20, 1987Garid, Inc.Glucose medical monitoring systemUS4648408 *May 7, 1985Mar 10, 1987Medscan B.V.Blood sampling unitUS4650547 *Dec 20, 1985Mar 17, 1987The Regents Of The University Of CaliforniaMethod and membrane applicable to implantable sensorUS4653513 *Aug 9, 1985Mar 31, 1987Dombrowski Mitchell PBlood samplerUS4654197 *Oct 12, 1984Mar 31, 1987Aktiebolaget LeoCuvette for sampling and analysisUS4655880 *Aug 1, 1983Apr 7, 1987Case Western Reserve UniversityApparatus and method for sensing species, substances and substrates using oxidaseUS4717673 *Nov 19, 1985Jan 5, 1988Massachusetts Institute Of TechnologyMicroelectrochemical devicesUS4721601 *Nov 23, 1984Jan 26, 1988Massachusetts Institute Of TechnologyMolecule-based microelectronic devicesUS4721677 *May 7, 1987Jan 26, 1988Children's Hospital Medical CenterImplantable gas-containing biosensor and method for measuring an analyte such as glucoseUS4726378 *Apr 11, 1986Feb 23, 1988Minnesota Mining And Manufacturing CompanyAdjustable magnetic supercutaneous device and transcutaneous coupling apparatusUS4726716 *Jul 21, 1986Feb 23, 1988Mcguire Thomas VFastener for catheterUS4731726 *May 19, 1986Mar 15, 1988Healthware CorporationPatient-operated glucose monitor and diabetes management systemUS4795707 *Nov 25, 1985Jan 3, 1989Hitachi, Ltd.Electrochemical sensor having three layer membrane containing immobilized enzymesUS4796634 *Aug 9, 1985Jan 10, 1989Lawrence Medical Systems, Inc.Methods and apparatus for monitoring cardiac outputUS4803625 *Jun 30, 1986Feb 7, 1989Buddy Systems, Inc.Personal health monitorUS4805624 *Apr 14, 1987Feb 21, 1989The Montefiore Hospital Association Of Western PaLow-potential electrochemical redox sensorsUS4813424 *Dec 23, 1987Mar 21, 1989University Of New MexicoLong-life membrane electrode for non-ionic speciesUS4815469 *Mar 10, 1988Mar 28, 1989Siemens-Pacesetter, Inc.Implantable blood oxygen sensor and method of useUS4890620 *Feb 17, 1988Jan 2, 1990The Regents Of The University Of CaliforniaTwo-dimensional diffusion glucose substrate sensing electrodeUS4890621 *Jan 19, 1988Jan 2, 1990Northstar Research Institute, Ltd.Continuous glucose monitoring and a system utilized thereforUS4894137 *Sep 14, 1987Jan 16, 1990Omron Tateisi Electronics Co.Enzyme electrodeUS4897162 *Feb 2, 1988Jan 30, 1990The Cleveland Clinic FoundationPulse voltammetryUS4897173 *Jun 19, 1986Jan 30, 1990Matsushita Electric Industrial Co., Ltd.Biosensor and method for making the sameUS4899839 *Jun 14, 1989Feb 13, 1990Dessertine Albert LCompliance and patient status monitoring system and methodUS4909908 *Oct 27, 1988Mar 20, 1990Pepi RossElectrochemical cncentration detector methodUS4911794 *Jun 18, 1987Mar 27, 1990Molecular Devices CorporationMeasuring with zero volume cellUS4986271 *Jul 19, 1989Jan 22, 1991The University Of New MexicoVivo refillable glucose sensorUS4990845 *Dec 18, 1989Feb 5, 1991Alfred E. Mann Foundation For Scientific ResearchFloating current sourceUS4991582 *Sep 22, 1989Feb 12, 1991Alfred E. Mann Foundation For Scientific ResearchHermetically sealed ceramic and metal package for electronic devices implantable in living bodiesUS4994068 *Nov 24, 1989Feb 19, 1991Unidex, Inc.Combination sterile pad support and lancet containing lancet disposal elementUS4994167 *Jul 7, 1988Feb 19, 1991Markwell Medical Institute, Inc.Biological fluid measuring deviceUS4995402 *Oct 12, 1988Feb 26, 1991Thorne, Smith, Astill Technologies, Inc.Medical droplet whole blood and like monitoringUS5000180 *Jul 31, 1989Mar 19, 1991Biomedical Systems Inc.Polarographic-amperometric three-electrode sensorUS5001054 *Jul 31, 1990Mar 19, 1991Becton, Dickinson And CompanyMethod for monitoring glucoseUS5002054 *Jun 2, 1989Mar 26, 1991Ash Medical Systems, Inc.Interstitial filtration and collection device and method for long-term monitoring of physiological constituents of the bodyUS5078854 *Jan 22, 1990Jan 7, 1992Mallinckrodt Sensor Systems, Inc.Polarographic chemical sensor with external reference electrodeUS5082550 *Dec 11, 1989Jan 21, 1992The United States Of America As Represented By The Department Of EnergyEnzyme electrochemical sensor electrode and method of making itUS5082786 *Nov 28, 1988Jan 21, 1992Nec CorporationGlucose sensor with gel-immobilized glucose oxidase and gluconolactonaseUS5084828 *Sep 29, 1989Jan 28, 1992Healthtech Services Corp.Interactive medication delivery systemUS5089112 *Jan 11, 1990Feb 18, 1992Associated Universities, Inc.Electrochemical biosensor based on immobilized enzymes and redox polymersUS5094951 *Jun 19, 1989Mar 10, 1992Chiron CorporationProduction of glucose oxidase in recombinant systemsUS5095904 *Sep 4, 1990Mar 17, 1992Cochlear Pty. Ltd.Multi-peak speech processionUS5096560 *May 29, 1990Mar 17, 1992Mitsubishi Petrochemical Co., Ltd.Electrode for electrochemical detectorsUS5096836 *Sep 19, 1990Mar 17, 1992Boehringer Mannheim GmbhDiagnostic test carrierUS5176644 *Nov 29, 1990Jan 5, 1993Minimed Technologies, Ltd.Medication infusion pump with improved liquid-vapor pressure reservoirUS5176662 *Aug 23, 1990Jan 5, 1993Minimed Technologies, Ltd.Subcutaneous injection set with improved cannula mounting arrangementUS5182707 *Jul 23, 1990Jan 26, 1993Healthdyne, Inc.Apparatus for recording reagent test strip data by comparison to color lights on a reference panelUS5184359 *Aug 22, 1991Feb 9, 1993Toto Ltd.Stool-type apparatus for sampling and assay of urine with swingable carriageUS5185256 *Oct 15, 1991Feb 9, 1993Matsushita Electric Industrial Co., Ltd.Method for making a biosensorUS5190041 *Dec 27, 1991Mar 2, 1993Palti Yoram ProfSystem for monitoring and controlling blood glucoseUS5192415 *Mar 2, 1992Mar 9, 1993Matsushita Electric Industrial Co., Ltd.Biosensor utilizing enzyme and a method for producing the sameUS5192416 *Apr 9, 1991Mar 9, 1993New Mexico State University Technology Transfer CorporationMethod and apparatus for batch injection analysisUS5193539 *Dec 18, 1991Mar 16, 1993Alfred E. Mann Foundation For Scientific ResearchImplantable microstimulatorUS5193540 *Dec 18, 1991Mar 16, 1993Alfred E. Mann Foundation For Scientific ResearchStructure and method of manufacture of an implantable microstimulatorUS5197322 *Nov 29, 1990Mar 30, 1993Minimed Technologies, Ltd.Pressure reservoir filling process for an implantable medication infusion pumpUS5198367 *Jun 9, 1989Mar 30, 1993Masuo AizawaHomogeneous amperometric immunoassayUS5275159 *Mar 20, 1992Jan 4, 1994Madaus Schwarzer Medizintechnik Gmbh & Co. KgMethod and apparatus for diagnosis of sleep disordersUS5278079 *Sep 2, 1992Jan 11, 1994Enzymatics, Inc.Sealing device and method for inhibition of flow in capillary measuring devicesUS5279294 *Mar 26, 1990Jan 18, 1994Cascade Medical, Inc.Medical diagnostic systemUS5282950 *Jul 14, 1992Feb 1, 1994Boehringer Mannheim GmbhElectrochemical analysis systemUS5284156 *Aug 30, 1991Feb 8, 1994M3 Systems, Inc.Automatic tissue sampling apparatusUS5285792 *Jan 10, 1992Feb 15, 1994Physio-Control CorporationSystem for producing prioritized alarm messages in a medical instrumentUS5286362 *Apr 27, 1993Feb 15, 1994Boehringer Mannheim GmbhMethod and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds thereforUS5286364 *Mar 29, 1991Feb 15, 1994Rutgers UniversitySurface-modified electochemical biosensorUS5288636 *Dec 14, 1990Feb 22, 1994Boehringer Mannheim CorporationEnzyme electrode systemUS5291887 *Jun 2, 1992Mar 8, 1994Anesta CorporationApparatus and methods for noninvasive blood substance monitoringUS5293546 *Apr 17, 1991Mar 8, 1994Martin Marietta CorporationOxide coated metal grid electrode structure in display devicesUS5293877 *Dec 11, 1991Mar 15, 1994Sherwood Ims, Inc.Body temperature thermometer and method fo measuring human body temperature utilizing calibration mappingUS5609575 *Apr 4, 1995Mar 11, 1997Graseby Medical LimitedInfusion pump and method with dose-rate calculationUS20030028089 *Jul 31, 2001Feb 6, 2003Galley Paul J.Diabetes management system* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS7653425Jan 26, 2010Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring systemUS7679407Apr 27, 2004Mar 16, 2010Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systemsUS7697967Sep 28, 2006Apr 13, 2010Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS7736310Jan 30, 2006Jun 15, 2010Abbott Diabetes Care Inc.On-body medical device securementUS7756561Sep 30, 2005Jul 13, 2010Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systemsUS7766829Nov 4, 2005Aug 3, 2010Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS7768386Jul 31, 2007Aug 3, 2010Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS7768387Apr 14, 2008Aug 3, 2010Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS7768408May 17, 2006Aug 3, 2010Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS7801582Mar 31, 2006Sep 21, 2010Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS7811231Oct 12, 2010Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS7822455Oct 26, 2010Abbott Diabetes Care Inc.Analyte sensors and methods of useUS7826382Nov 2, 2010Abbott Diabetes Care Inc.Close proximity communication device and methodsUS7826879Feb 28, 2006Nov 2, 2010Abbott Diabetes Care Inc.Analyte sensors and methods of useUS7860544Mar 7, 2007Dec 28, 2010Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7869853Jan 11, 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7883464Sep 30, 2005Feb 8, 2011Abbott Diabetes Care Inc.Integrated transmitter unit and sensor introducer mechanism and methods of useUS7884729Aug 2, 2010Feb 8, 2011Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS7885698Feb 28, 2006Feb 8, 2011Abbott Diabetes Care Inc.Method and system for providing continuous calibration of implantable analyte sensorsUS7885699Feb 8, 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS7920907Jun 7, 2007Apr 5, 2011Abbott Diabetes Care Inc.Analyte monitoring system and methodUS7922458Dec 29, 2008Apr 12, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS7928850Apr 19, 2011Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS7948369Aug 2, 2010May 24, 2011Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS7951080May 31, 2011Abbott Diabetes Care Inc.On-body medical device securementUS7976778Jul 12, 2011Abbott Diabetes Care Inc.Blood glucose tracking apparatusUS7993108Aug 9, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS7993109Aug 9, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS7996158May 14, 2008Aug 9, 2011Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8029245Oct 4, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS8029250Oct 4, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS8029441Feb 28, 2006Oct 4, 2011Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management systemUS8029459Oct 4, 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring systemUS8029460Oct 4, 2011Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring systemUS8047811Dec 29, 2008Nov 1, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS8047812Dec 29, 2008Nov 1, 2011Abbott Diabetes Care Inc.Variable volume, shape memory actuated insulin dispensing pumpUS8066639Jun 4, 2004Nov 29, 2011Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8086292Oct 27, 2009Dec 27, 2011Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS8089363Jan 3, 2012Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS8103456Jan 24, 2012Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8103471May 14, 2008Jan 24, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8112138Sep 26, 2008Feb 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing rechargeable power in data monitoring and management systemsUS8112240Apr 29, 2005Feb 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing leak detection in data monitoring and management systemsUS8116840Oct 30, 2007Feb 14, 2012Abbott Diabetes Care Inc.Method of calibrating of an analyte-measurement device, and associated methods, devices and systemsUS8121857Feb 14, 2008Feb 21, 2012Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8123686Mar 1, 2007Feb 28, 2012Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systemsUS8135548Oct 26, 2007Mar 13, 2012Abbott Diabetes Care Inc.Method, system and computer program product for real-time detection of sensitivity decline in analyte sensorsUS8140142Apr 14, 2008Mar 20, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS8140312Jan 31, 2008Mar 20, 2012Abbott Diabetes Care Inc.Method and system for determining analyte levelsUS8149103May 23, 2011Apr 3, 2012Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage amplification in a medical deviceUS8149117Aug 29, 2009Apr 3, 2012Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8156070Sep 5, 2008Apr 10, 2012Roche Diagnostics Operations, Inc.Insulin pump programming software with basal profile preview featureUS8160900Apr 17, 2012Abbott Diabetes Care Inc.Analyte monitoring and management device and method to analyze the frequency of user interaction with the deviceUS8162829Mar 30, 2009Apr 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8175673Nov 9, 2009May 8, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8177716Dec 21, 2009May 15, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8185181May 22, 2012Abbott Diabetes Care Inc.Method and apparatus for detecting false hypoglycemic conditionsUS8187183Oct 11, 2010May 29, 2012Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS8208984Mar 9, 2010Jun 26, 2012Smiths Medical Asd, Inc.Correction factor testing using frequent blood glucose inputUS8211016Jul 3, 2012Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS8216137Jul 20, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS8216138Jul 10, 2012Abbott Diabetes Care Inc.Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentrationUS8219173Sep 30, 2008Jul 10, 2012Abbott Diabetes Care Inc.Optimizing analyte sensor calibrationUS8219174Jun 29, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8219175Jun 29, 2009Jul 10, 2012Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8219222May 6, 2010Jul 10, 2012Smiths Medical Asd, Inc.Expert system for pump therapyUS8221345Jul 17, 2012Smiths Medical Asd, Inc.Insulin pump based expert systemUS8224413Oct 10, 2008Jul 17, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8224415Jan 29, 2009Jul 17, 2012Abbott Diabetes Care Inc.Method and device for providing offset model based calibration for analyte sensorUS8226555Mar 18, 2009Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226557Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226558Sep 27, 2010Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8226891Jul 24, 2012Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS8231532Apr 30, 2007Jul 31, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8231562Jul 31, 2012Roche Diagnostics Operations, Inc.Insulin pump configuration programming invalid settings notification and correctionUS8235896Dec 21, 2009Aug 7, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8236242Feb 12, 2010Aug 7, 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methodsUS8237715Sep 5, 2008Aug 7, 2012Roche Diagnostics Operations, Inc.Method and system for manipulating groups of data representations of a graphical displayUS8239166Aug 7, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8252229Apr 10, 2009Aug 28, 2012Abbott Diabetes Care Inc.Method and system for sterilizing an analyte sensorUS8255031Mar 17, 2009Aug 28, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8260392Sep 4, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8260558May 14, 2008Sep 4, 2012Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8265726Sep 11, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8268243Dec 28, 2009Sep 18, 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methodsUS8273022Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8275439Nov 9, 2009Sep 25, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8287454Oct 16, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8306598Nov 9, 2009Nov 6, 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8333714Sep 10, 2006Dec 18, 2012Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unitUS8343092Nov 24, 2009Jan 1, 2013Abbott Diabetes Care Inc.Method and system for providing integrated medication infusion and analyte monitoring systemUS8343093May 28, 2010Jan 1, 2013Abbott Diabetes Care Inc.Fluid delivery device with autocalibrationUS8344966Jan 31, 2006Jan 1, 2013Abbott Diabetes Care Inc.Method and system for providing a fault tolerant display unit in an electronic deviceUS8346335Jan 1, 2013Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8346336Mar 18, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8346337Jun 30, 2009Jan 1, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8353829Dec 21, 2009Jan 15, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8357091Jan 22, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8362904Jan 29, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8366614Mar 30, 2009Feb 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8368556Feb 5, 2013Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS8372005Dec 21, 2009Feb 12, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8374668Oct 23, 2008Feb 12, 2013Abbott Diabetes Care Inc.Analyte sensor with lag compensationUS8376945Nov 23, 2009Feb 19, 2013Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring systemUS8377031Aug 31, 2008Feb 19, 2013Abbott Diabetes Care Inc.Closed loop control system with safety parameters and methodsUS8380273Feb 19, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8391945Mar 17, 2009Mar 5, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8401873May 29, 2008Mar 19, 2013Bayer Healthcare LlcHealth data management deviceUS8409093Apr 2, 2013Abbott Diabetes Care Inc.Assessing measures of glycemic variabilityUS8409131Mar 7, 2007Apr 2, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8417311Sep 14, 2009Apr 9, 2013Optiscan Biomedical CorporationFluid component analysis system and method for glucose monitoring and controlUS8417545Apr 9, 2013Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8427298Apr 23, 2013Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage amplification in a medical deviceUS8444560May 14, 2008May 21, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8449524Jun 30, 2011May 28, 2013Optiscan Biomedical CorporationFluid component analysis systems and methods for glucose monitoring and controlUS8452953May 28, 2013Roche Diagnostics Operations, Inc.Insulin pump programming software for selectively modifying configuration dataUS8456301May 8, 2008Jun 4, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8461985May 8, 2008Jun 11, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8465425Jun 18, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8467972Jun 18, 2013Abbott Diabetes Care Inc.Closed loop blood glucose control algorithm analysisUS8471714Dec 30, 2011Jun 25, 2013Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS8473021Jul 31, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8473022Jan 30, 2009Jun 25, 2013Abbott Diabetes Care Inc.Analyte sensor with time lag compensationUS8473220Jan 23, 2012Jun 25, 2013Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8478557Jul 30, 2010Jul 2, 2013Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracyUS8480580Apr 19, 2007Jul 9, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8483967Apr 28, 2010Jul 9, 2013Abbott Diabetes Care Inc.Method and system for providing real time analyte sensor calibration with retrospective backfillUS8484005Mar 19, 2012Jul 9, 2013Abbott Diabetes Care Inc.Method and system for determining analyte levelsUS8495515Dec 18, 2009Jul 23, 2013Roche Diagnostics Operations, Inc.Methods, systems and computer readable media for modifying parameters of a configuration fileUS8497777Apr 15, 2010Jul 30, 2013Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS8506482Feb 7, 2011Aug 13, 2013Abbott Diabetes Care Inc.Method and system for providing continuous calibration of implantable analyte sensorsUS8509107Nov 1, 2010Aug 13, 2013Abbott Diabetes Care Inc.Close proximity communication device and methodsUS8512239Apr 20, 2009Aug 20, 2013Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8512243Sep 30, 2005Aug 20, 2013Abbott Diabetes Care Inc.Integrated introducer and transmitter assembly and methods of useUS8512246Mar 15, 2010Aug 20, 2013Abbott Diabetes Care Inc.Method and apparatus for providing peak detection circuitry for data communication systemsUS8514086Aug 30, 2010Aug 20, 2013Abbott Diabetes Care Inc.Displays for a medical deviceUS8515517Sep 30, 2009Aug 20, 2013Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensorUS8532933Jun 18, 2010Sep 10, 2013Roche Diagnostics Operations, Inc.Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkersUS8532935Jul 16, 2012Sep 10, 2013Abbott Diabetes Care Inc.Method and device for providing offset model based calibration for analyte sensorUS8543183Dec 23, 2011Sep 24, 2013Abbott Diabetes Care Inc.Analyte monitoring and management system and methods thereforUS8545403Dec 28, 2006Oct 1, 2013Abbott Diabetes Care Inc.Medical device insertionUS8560038May 14, 2008Oct 15, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8560082Jan 30, 2009Oct 15, 2013Abbott Diabetes Care Inc.Computerized determination of insulin pump therapy parameters using real time and retrospective data processingUS8571624Dec 29, 2004Oct 29, 2013Abbott Diabetes Care Inc.Method and apparatus for mounting a data transmission device in a communication systemUS8571808Jan 23, 2012Oct 29, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8579853Oct 31, 2006Nov 12, 2013Abbott Diabetes Care Inc.Infusion devices and methodsUS8583205Apr 16, 2010Nov 12, 2013Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8585591Jul 10, 2010Nov 19, 2013Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS8591410Jun 1, 2009Nov 26, 2013Abbott Diabetes Care Inc.Method and apparatus for providing glycemic controlUS8593109Nov 3, 2009Nov 26, 2013Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS8593287Jul 20, 2012Nov 26, 2013Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS8597188Jun 20, 2008Dec 3, 2013Abbott Diabetes Care Inc.Health management devices and methodsUS8597189Mar 3, 2009Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8597575Jul 23, 2012Dec 3, 2013Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS8600681May 14, 2008Dec 3, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8602991Jun 7, 2010Dec 10, 2013Abbott Diabetes Care Inc.Analyte sensor introducer and methods of useUS8612159Feb 16, 2004Dec 17, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8612163Aug 30, 2012Dec 17, 2013Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8613703May 29, 2008Dec 24, 2013Abbott Diabetes Care Inc.Insertion devices and methodsUS8613892Jun 30, 2009Dec 24, 2013Abbott Diabetes Care Inc.Analyte meter with a moveable head and methods of using the sameUS8617069Jun 20, 2008Dec 31, 2013Abbott Diabetes Care Inc.Health monitorUS8617071Jun 21, 2007Dec 31, 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8617381Jun 23, 2010Dec 31, 2013Bayer Healthcare LlcSystem and apparatus for determining temperatures in a fluid analyte systemUS8622903May 25, 2012Jan 7, 2014Abbott Diabetes Care Inc.Continuous glucose monitoring system and methods of useUS8622906Dec 21, 2009Jan 7, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8622988Aug 31, 2008Jan 7, 2014Abbott Diabetes Care Inc.Variable rate closed loop control and methodsUS8635046Jun 22, 2011Jan 21, 2014Abbott Diabetes Care Inc.Method and system for evaluating analyte sensor response characteristicsUS8638220May 23, 2011Jan 28, 2014Abbott Diabetes Care Inc.Method and apparatus for providing data communication in data monitoring and management systemsUS8641618Jun 26, 2008Feb 4, 2014Abbott Diabetes Care Inc.Method and structure for securing a monitoring device elementUS8641619Dec 21, 2009Feb 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8647269Apr 20, 2009Feb 11, 2014Abbott Diabetes Care Inc.Glucose measuring device for use in personal area networkUS8649841Apr 3, 2007Feb 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8652043Jul 20, 2012Feb 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8653977Jun 21, 2013Feb 18, 2014Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS8660627Mar 17, 2009Feb 25, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8665091Jun 30, 2009Mar 4, 2014Abbott Diabetes Care Inc.Method and device for determining elapsed sensor lifeUS8666469Nov 16, 2007Mar 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8668645Jan 3, 2003Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8670815Apr 30, 2007Mar 11, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8672844Feb 27, 2004Mar 18, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8676513Jun 21, 2013Mar 18, 2014Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS8676601Apr 8, 2013Mar 18, 2014Abbott Diabetes Care Inc.Device and method for automatic data acquisition and/or detectionUS8682615Aug 4, 2012Mar 25, 2014Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS8684930Jun 29, 2009Apr 1, 2014Abbott Diabetes Care Inc.Method of calibrating an analyte-measurement device, and associated methods, devices and systemsUS8684996 *Mar 2, 2011Apr 1, 2014Roche Diagnostics International AgMethod and apparatus for setting a basal rate profile for an insulin pumpUS8688188Jun 30, 2009Apr 1, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8698615Apr 22, 2013Apr 15, 2014Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS8710993Nov 21, 2012Apr 29, 2014Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereofUS8718739Dec 28, 2012May 6, 2014Abbott Diabetes Care Inc.Analyte sensor calibration managementUS8718949May 25, 2012May 6, 2014Tandem Diabetes Care, Inc.Insulin pump with blood glucose modulesUS8718958Mar 12, 2012May 6, 2014Abbott Diabetes Care Inc.Method, system and computer program product for real-time detection of sensitivity decline in analyte sensorsUS8718965Jun 24, 2013May 6, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte monitoring system calibration accuracyUS8721585Mar 30, 2012May 13, 2014Dex Com, Inc.Integrated delivery device for continuous glucose sensorUS8727982Jun 25, 2012May 20, 2014Abbott Diabetes Care Inc.Method and system for providing integrated analyte monitoring and infusion system therapy managementUS8730058Jul 29, 2013May 20, 2014Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS8732188Feb 15, 2008May 20, 2014Abbott Diabetes Care Inc.Method and system for providing contextual based medication dosage determinationUS8734344May 29, 2011May 27, 2014Abbott Diabetes Care Inc.On-body medical device securementUS8734346Apr 30, 2007May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8734348Mar 17, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8734422Aug 31, 2008May 27, 2014Abbott Diabetes Care Inc.Closed loop control with improved alarm functionsUS8737259Aug 5, 2013May 27, 2014Abbott Diabetes Care Inc.Close proximity communication device and methodsUS8738109Mar 3, 2009May 27, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8744545Mar 3, 2009Jun 3, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8744547Jul 9, 2012Jun 3, 2014Abbott Diabetes Care Inc.Optimizing analyte sensor calibrationUS8755938May 13, 2011Jun 17, 2014Roche Diagnostics Operations, Inc.Systems and methods for handling unacceptable values in structured collection protocolsUS8764657Mar 30, 2012Jul 1, 2014Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS8765059Oct 27, 2010Jul 1, 2014Abbott Diabetes Care Inc.Blood glucose tracking apparatusUS8766803May 13, 2011Jul 1, 2014Roche Diagnostics Operations, Inc.Dynamic data collectionUS8771183Feb 16, 2005Jul 8, 2014Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS8774887Mar 24, 2007Jul 8, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8775961May 22, 2013Jul 8, 2014Roche Diagnostics Operations, Inc.Methods, systems and computer readable media for modifying parameters of a configuration fileUS8795252Oct 16, 2009Aug 5, 2014Abbott Diabetes Care Inc.Robust closed loop control and methodsUS8798934Jul 23, 2010Aug 5, 2014Abbott Diabetes Care Inc.Real time management of data relating to physiological control of glucose levelsUS8801657Oct 20, 2010Aug 12, 2014Tandem Diabetes Care, Inc.Pump with therapy coachingUS8802006Aug 27, 2012Aug 12, 2014Abbott Diabetes Care Inc.Method and system for sterilizing an analyte sensorUS8808228Jun 5, 2008Aug 19, 2014Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensorUS8816862Aug 19, 2013Aug 26, 2014Abbott Diabetes Care Inc.Displays for a medical deviceUS8834366Jul 31, 2007Sep 16, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibrationUS8840553Feb 26, 2009Sep 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8840582May 29, 2012Sep 23, 2014Tandem Diabetes Care, Inc.Infusion pump with activity monitoringUS8849458Jun 18, 2010Sep 30, 2014Roche Diagnostics Operations, Inc.Collection device with selective display of test results, method and computer program product thereofUS8852101Sep 30, 2009Oct 7, 2014Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS8862198Dec 17, 2012Oct 14, 2014Abbott Diabetes Care Inc.Method and system for providing an integrated analyte sensor insertion device and data processing unitUS8876755Jul 14, 2009Nov 4, 2014Abbott Diabetes Care Inc.Closed loop control system interface and methodsUS8880137Apr 18, 2003Nov 4, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8880138Sep 30, 2005Nov 4, 2014Abbott Diabetes Care Inc.Device for channeling fluid and methods of useUS8882741Apr 30, 2012Nov 11, 2014Dexcom, Inc.Integrated delivery device for continuous glucose sensorUS8915850Mar 28, 2014Dec 23, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8920319Dec 28, 2012Dec 30, 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8920401Apr 30, 2012Dec 30, 2014Dexcom, Inc.Integrated delivery device for continuous glucose sensorUS8924159Jun 1, 2009Dec 30, 2014Abbott Diabetes Care Inc.Method and apparatus for providing glycemic controlUS8926585Mar 30, 2012Jan 6, 2015Dexcom, Inc.Integrated delivery device for continuous glucose sensorUS8930203Feb 3, 2010Jan 6, 2015Abbott Diabetes Care Inc.Multi-function analyte test device and methods thereforUS8932216Aug 7, 2006Jan 13, 2015Abbott Diabetes Care Inc.Method and system for providing data management in integrated analyte monitoring and infusion systemUS8933664Nov 25, 2013Jan 13, 2015Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS8937540Feb 24, 2014Jan 20, 2015Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS8974386Nov 1, 2005Mar 10, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS8986208Sep 30, 2008Mar 24, 2015Abbott Diabetes Care Inc.Analyte sensor sensitivity attenuation mitigationUS8993331Aug 31, 2010Mar 31, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methods for managing power and noiseUS9000929Nov 22, 2013Apr 7, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9008743Apr 14, 2008Apr 14, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS9011331Dec 29, 2004Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9011332Oct 30, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9014773Mar 7, 2007Apr 21, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9031630Nov 1, 2010May 12, 2015Abbott Diabetes Care Inc.Analyte sensors and methods of useUS9035767May 30, 2013May 19, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9039975Dec 2, 2013May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring devices and methods thereforUS9042953Mar 2, 2007May 26, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9050041May 21, 2012Jun 9, 2015Abbott Diabetes Care Inc.Method and apparatus for detecting false hypoglycemic conditionsUS9050413Apr 30, 2012Jun 9, 2015Dexcom, Inc.Integrated delivery device for continuous glucose sensorUS9060719Dec 13, 2013Jun 23, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS9064107Sep 30, 2013Jun 23, 2015Abbott Diabetes Care Inc.Infusion devices and methodsUS9066694Apr 3, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066695Apr 12, 2007Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066697Oct 27, 2011Jun 30, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9066709Mar 17, 2014Jun 30, 2015Abbott Diabetes Care Inc.Method and device for early signal attenuation detection using blood glucose measurementsUS9069536Oct 30, 2012Jun 30, 2015Abbott Diabetes Care Inc.Electronic devices having integrated reset systems and methods thereofUS9072477Jun 21, 2007Jul 7, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9078607Jun 17, 2013Jul 14, 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9088452Jan 31, 2013Jul 21, 2015Abbott Diabetes Care Inc.Method and system for providing data communication in continuous glucose monitoring and management systemUS9095290Feb 27, 2012Aug 4, 2015Abbott Diabetes Care Inc.Method and apparatus for providing rolling data in communication systemsUS9097650Dec 2, 2013Aug 4, 2015Bayer Healthcare LlcSystem and apparatus for determining temperatures in a fluid analyte systemUS9113828Jul 9, 2012Aug 25, 2015Abbott Diabetes Care Inc.Method and system for providing analyte monitoringUS9117015Jun 21, 2011Aug 25, 2015Roche Diagnostics Operations, Inc.Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection deviceUS9125548May 14, 2008Sep 8, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in a medical communication systemUS9155843Jul 26, 2012Oct 13, 2015Dexcom, Inc.Integrated delivery device for continuous glucose sensorUS9177456Jun 10, 2013Nov 3, 2015Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9178752Apr 25, 2014Nov 3, 2015Abbott Diabetes Care Inc.Analyte monitoring system having an alertUS9184875Apr 25, 2014Nov 10, 2015Abbott Diabetes Care, Inc.Close proximity communication device and methodsUS9186098Mar 24, 2011Nov 17, 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9186113Aug 11, 2014Nov 17, 2015Abbott Diabetes Care Inc.Displays for a medical deviceUS9189598Mar 9, 2013Nov 17, 2015Bayer Healthcare LlcFluid analyte meterUS9204827Apr 14, 2008Dec 8, 2015Abbott Diabetes Care Inc.Method and apparatus for providing data processing and control in medical communication systemUS9215992Mar 24, 2011Dec 22, 2015Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9226701Apr 28, 2010Jan 5, 2016Abbott Diabetes Care Inc.Error detection in critical repeating data in a wireless sensor systemUS9226714Jan 8, 2015Jan 5, 2016Abbott Diabetes Care Inc.Displays for a medical deviceUS9259175Oct 23, 2006Feb 16, 2016Abbott Diabetes Care, Inc.Flexible patch for fluid delivery and monitoring body analytesUS9265453Mar 24, 2011Feb 23, 2016Abbott Diabetes Care Inc.Medical device inserters and processes of inserting and using medical devicesUS9289179Apr 11, 2014Mar 22, 2016Abbott Diabetes Care Inc.Mitigating single point failure of devices in an analyte monitoring system and methods thereofUS9302045Apr 5, 2013Apr 5, 2016Optiscan Biomedical CorporationFluid component analysis system and method for glucose monitoring and controlUS9310230Jun 24, 2013Apr 12, 2016Abbott Diabetes Care Inc.Method and system for providing real time analyte sensor calibration with retrospective backfillUS9314195Aug 31, 2010Apr 19, 2016Abbott Diabetes Care Inc.Analyte signal processing device and methodsUS9314198Apr 3, 2015Apr 19, 2016Abbott Diabetes Care Inc.Analyte monitoring system and methodsUS9317656Nov 21, 2012Apr 19, 2016Abbott Diabetes Care Inc.Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereofUS9320461Sep 29, 2010Apr 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing notification function in analyte monitoring systemsUS9320462May 5, 2014Apr 26, 2016Abbott Diabetes Care Inc.Analyte sensor calibration managementUS9320468Jun 21, 2013Apr 26, 2016Abbott Diabetes Care Inc.Analyte sensor with time lag compensationUS9323898Nov 15, 2013Apr 26, 2016Abbott Diabetes Care Inc.Method and system for providing basal profile modification in analyte monitoring and management systemsUS9326707Nov 10, 2009May 3, 2016Abbott Diabetes Care Inc.Alarm characterization for analyte monitoring devices and systemsUS9326709Mar 9, 2011May 3, 2016Abbott Diabetes Care Inc.Systems, devices and methods for managing glucose levelsUS9326714Jun 29, 2010May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9326716Dec 5, 2014May 3, 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of useUS9326727May 15, 2014May 3, 2016Abbott Diabetes Care Inc.On-body medical device securementUS9330237 *Dec 24, 2008May 3, 2016Medtronic Minimed, Inc.Pattern recognition and filtering in a therapy management systemUS9332933Sep 29, 2014May 10, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor insertionUS9332934Feb 8, 2013May 10, 2016Abbott Diabetes Care Inc.Analyte sensor with lag compensationUS9332944Jan 31, 2014May 10, 2016Abbott Diabetes Care Inc.Method and system for providing data management in data monitoring systemUS9339217Nov 21, 2012May 17, 2016Abbott Diabetes Care Inc.Analyte monitoring system and methods of useUS9351669Sep 30, 2010May 31, 2016Abbott Diabetes Care Inc.Interconnect for on-body analyte monitoring deviceUS9357959Aug 19, 2013Jun 7, 2016Abbott Diabetes Care Inc.Method and system for dynamically updating calibration parameters for an analyte sensorUS9364149Oct 3, 2011Jun 14, 2016Abbott Diabetes Care Inc.Analyte sensor transmitter unit configuration for a data monitoring and management systemUS9380971Dec 5, 2014Jul 5, 2016Abbott Diabetes Care Inc.Method and system for powering an electronic deviceUS9390524Feb 3, 2014Jul 12, 2016Roche Diabetes Care, Inc.Method and apparatus for setting a basal rate profile for an insulin pumpUS9392969Aug 31, 2008Jul 19, 2016Abbott Diabetes Care Inc.Closed loop control and signal attenuation detectionUS9398872Aug 28, 2014Jul 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor calibrationUS9398882Sep 10, 2006Jul 26, 2016Abbott Diabetes Care Inc.Method and apparatus for providing analyte sensor and data processing deviceUS9402544Feb 1, 2010Aug 2, 2016Abbott Diabetes Care Inc.Analyte sensor and apparatus for insertion of the sensorUS9402570Dec 11, 2012Aug 2, 2016Abbott Diabetes Care Inc.Analyte sensor devices, connections, and methodsUS9402584Jan 14, 2015Aug 2, 2016Abbott Diabetes Care Inc.Method and apparatus for providing dynamic multi-stage signal amplification in a medical deviceUS9408566Feb 13, 2013Aug 9, 2016Abbott Diabetes Care Inc.Method and system for providing calibration of an analyte sensor in an analyte monitoring systemUS9414782Sep 14, 2012Aug 16, 2016Optiscan Biomedical CorporationFluid component analysis systems and methods for glucose monitoring and controlUS9439586Mar 29, 2013Sep 13, 2016Abbott Diabetes Care Inc.Assessing measures of glycemic variabilityUS20080300534 *May 30, 2007Dec 4, 2008Michael BlomquistInsulin pump based expert systemUS20090082693 *Dec 29, 2004Mar 26, 2009Therasense, Inc.Method and apparatus for providing temperature sensor module in a data communication systemUS20100010329 *Jul 14, 2009Jan 14, 2010Abbott Diabetes Care Inc.Closed Loop Control System Interface and MethodsUS20100064236 *Mar 11, 2010Schuyler BuckInsulin pump programming software with basal profile preview featureUS20100064243 *Sep 5, 2008Mar 11, 2010Schuyler BuckMethod and system for manipulating groups of data representations of a graphical displayUS20100064257 *Sep 5, 2008Mar 11, 2010Roche Diagnostics Operations, Inc.Insulin pump configuration programming invalid settings notification and correctionUS20100077198 *Sep 5, 2008Mar 25, 2010Schuyler BuckInsulin pump programming software for selectively modifying configuration dataUS20100161236 *Dec 24, 2008Jun 24, 2010Gary CohenPattern Recognition and Filtering in a Therapy Management SystemUS20100212675 *Aug 26, 2010Roche Diagnostics Operations, Inc.Structured testing method for diagnostic or therapy support of a patient with a chronic disease and devices thereofUS20100218132 *Aug 26, 2010Roche Diagnostics Operations, Inc.Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection deviceUS20100222765 *Mar 9, 2010Sep 2, 2010Smiths Medical Asd, Inc.Correction factor testing using frequent blood glucose inputUS20100274751 *May 6, 2010Oct 28, 2010Smith Medical Asd, Inc.Expert system for insulin pump therapyUS20100319436 *Jun 23, 2010Dec 23, 2010Bayer Healthcare LlcSystem and Apparatus for Determining Temperatures in a Fluid Analyte SystemUS20110015511 *Jun 18, 2010Jan 20, 2011Roche Diagnostics Operations, Inc.Systems and methods for optimizing insulin dosageUS20110033833 *Feb 10, 2011Michael BlomquistPump with therapy coachingUS20110145747 *Jun 18, 2010Jun 16, 2011Roche Diagnostics Operations, Inc.Structured TailoringUS20110152656 *Jun 18, 2010Jun 23, 2011Roche Diagnostics Operations, Inc.Collection Device With Selective Display of Test Results, Method And Computer Program Product ThereofUS20110154237 *Dec 18, 2009Jun 23, 2011Roche Diagnostics Operations, Inc.Methods, systems and computer readable media for modifying parameters of a configuration fileUS20110178820 *Jul 21, 2011Roche Diagnostics Operations, Inc.Status Reporting Of A Structured Collection ProcedureUS20120059348 *Mar 2, 2011Mar 8, 2012Roche Diagnostics International Ltd.Method and Apparatus For Setting A Basal Rate Profile For An Insulin PumpUS20150335287 *Dec 20, 2013Nov 26, 2015Fibrotx O�Device to measure analytes in the skinCN103239208A *Apr 18, 2013Aug 14, 2013深圳市科曼医疗设备有限公司Monitor waveform display method and monitor waveform display systemWO2010009172A1 *Jul 14, 2009Jan 21, 2010Abbott Diabetes Care Inc.Closed loop control system interface and methodsWO2010089307A1 *Feb 3, 2010Aug 12, 2010Sanofi-Aventis Deutschland GmbhMedical system and method for providing information for glycemic controlWO2015009385A1 *Jun 17, 2014Jan 22, 2015Dexcom, Inc.Time averaged basal rate optimizer* Cited by examinerClassifications U.S. Classification600/322, 600/345, 604/65International ClassificationA61B5/00, A61B5/05, A61M31/00Cooperative ClassificationA61M2205/3303, A61M2230/201, G06F19/3468, A61M2205/52, A61M5/1723, A61B5/14532, A61B2560/0223, A61B5/4839European ClassificationA61B5/145G, A61B5/48J2Legal EventsDateCodeEventDescriptionMay 4, 2007ASAssignmentOwner name: ABBOTT DIABETES CARE, INC., CALIFORNIAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SLOAN, MARK K.;HAYTER, GARY;REEL/FRAME:019252/0016Effective date: 20070405Jan 28, 2014FPAYFee paymentYear of fee payment: 4RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services